Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QoL in IMBO study of lanreotide Autogel plus standard care versus standard care alone
2013-003176-12Phase 2Completed
- Sponsor
- Ipsen
- Start
- Jul 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial of lanreotide in malignant bowel obstruction (MBO) (2 arms), sponsored by Ipsen. Started Jul 2014; status: completed.
02
Drugs
lanreotide
03
Conditions
malignant bowel obstruction (MBO)
Beyond the preview
Go deeper on 2013-003176-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003176-12.